The primary driver of immune suppression is the glioma cells themselves, MDSCs, Tregs, and Tumor-Associated Microglia and Macrophages (TAMMs) through PD-L1 expression and TGF-β/IL-10 secretion. This evidence concerns the gene TGFB1 and glioma.